Abstract

Although the signal pathways mediating muscle protein synthesis and degradation are well characterized, the transcriptional processes modulating skeletal muscle mass and adaptive growth are poorly understood. Recently, studies in mouse models of muscle wasting or acutely exercised human muscle have suggested a potential role for the transcription factor signal transducer and activator of transcription 3 (STAT3), in adaptive growth. Hence, in the present study we sought to define the contribution of STAT3 to skeletal muscle adaptive growth. In contrast to previous work, two different resistance exercise protocols did not change STAT3 phosphorylation in human skeletal muscle. To directly address the role of STAT3 in load-induced (i.e., adaptive) growth, we studied the anabolic effects of 14 days of synergist ablation (SA) in skeletal muscle-specific STAT3 knockout (mKO) mice and their floxed, wild-type (WT) littermates. Plantaris muscle weight and fiber area in the nonoperated leg (control; CON) was comparable between genotypes. As expected, SA significantly increased plantaris weight, muscle fiber cross-sectional area, and anabolic signaling in WT mice, although interestingly, this induction was not impaired in STAT3 mKO mice. Collectively, these data demonstrate that STAT3 is not required for overload-mediated hypertrophy in mouse skeletal muscle.

Highlights

  • SKELETAL MUSCLE WASTING is a hallmark of several diseases, including cancer cachexia, chronic kidney disease (CKD), heart failure, and diabetes [4, 14]

  • synergist ablation (SA) reduced the relative levels of p-STAT3Y705 in musclespecific STAT3 knockout (mKO)-SA as opposed to the increase observed in WT-SA muscles (Fig. 1A)

  • Both skeletal muscle hypertrophy and regeneration strongly activate signal transducer and activator of transcription 3 (STAT3) in satellite cells [15, 17], suggesting that the nonmuscle p-STAT3Y705 detected in mKO potentially reflects the effect of SA on this cell population

Read more

Summary

Introduction

SKELETAL MUSCLE WASTING is a hallmark of several diseases, including cancer cachexia, chronic kidney disease (CKD), heart failure, and diabetes [4, 14]. We assessed the effects of 2 wk of synergist ablation (SA) on skeletal muscle hypertrophy in mice with skeletal musclespecific STAT3 knockout (mKO) [21] and their floxed/wildtype (WT) littermates. Both skeletal muscle hypertrophy and regeneration strongly activate STAT3 in satellite cells [15, 17], suggesting that the nonmuscle p-STAT3Y705 detected in mKO potentially reflects the effect of SA on this cell population.

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.